WanaCaps_xr Launches Class Specific Options

Boulder, Colo. - August 7, 2017 (Investorideas.com Newswire) WanaCapsxr, a family of extended release cannabis capsules that provide medicinal benefits for up to 12 hours, are now available in class specific options--Indica and Sativa--for the High THC formulation of the product. Class specific products allow patients more options for their symptom relief, with Sativa known as a more energetic selection, while Indica is often associated with a more relaxing effect.

Wana Brands, using technology from Cannabics Pharmaceuticals, developed the extended release formula and offers the product in five formulations: High THC Indica (10:1 ratio of THC to CBD); High THC Sativa (10:1 ratio of THC to CBD); High THC Hybrid (10:1 THC to CBD); High CBD Hybrid (10:1 ratio of CBD to THC); and Balanced THC:CBD Hybrid (1:1 ratio of THC to CBD). All formulations are available in both the medical and adult-use markets.

The extended release formula is unique because it allows patients to dose once or twice daily without the frequent need to re-dose. The world’s first extended release cannabis capsules, Wana Brands is expanding the launch of its capsules and other popular products through partnerships in emerging markets, both nationally and internationally with plans to enter new domestic and international markets over the next few years. WanaCapsxr perfectly address the desire by some states, such as Florida, New York and Maryland, to have their cannabis medicine take the form of traditional non-cannabis medications.

"Offering class specific WanaCapsxr gives patients more options for their treatment," said Nancy Whiteman, co-owner of Wana Brands. "It has been incredibly validating to hear from patients about how WanaCapsxr has changed their lives for the better. When taking the capsules, patients have reported that they have experienced pain reduction without having to dose every few hours. And as more and more communities deal with the deadly opioid epidemic, WanaCapsxr can also offer a pain relief alternative to addictive narcotics."

The extended release capsules address one of the major concerns of cannabis patients as compared to other forms of ingestion, which is that the initial high peak of cannabinoid activity soon after administration can cause uncomfortable side effects such as disorientation and dizziness. Composed from food grade materials, the XR formulation prolongs the effects of the active compounds by 25-35 percent in comparison to non-formulated capsules, extending the beneficial effects of the capsule up to 12 hours. Additionally, some medical patients prefer not to inhale cannabis. Others find the effects of edibles too strong or too variable. WanaCapsxr provide a stable, convenient and discreet option for patients who are looking for dosing alternatives.

The capsules contain two types of oil-based compounds known as "fractions." The fractions bind with the cannabinoids in different ways. The first fraction is highly bio-available and provides a quick onset of the therapeutic effects, generally within 20-30 minutes of taking the capsule. This first release of cannabinoids lasts for up to six hours. The second fraction then takes effect, releasing the remaining cannabinoids gradually for a steady, long lasting experience.

Wana Brands is the leading edibles company in Colorado, experiencing consistent month-over-month growth of market share in the incredibly competitive market. Wana Brands dominates, owning 23 percent of the Colorado market share, with the next closest competitor at 12 percent, according to BDS Analytics 2017 May brand share report. In Oregon, Wana is available in 280 of the state’s 375 dispensaries. The company launched in Nevada at the end of 2016, and has partnerships in Arizona and Illinois that will bring its products to those states in Q4 of 2017. Additionally, Wana Brands will launch in 2018 in Massachusetts and Maryland, and is in discussions with potential partners in California, Florida and Ohio, as well as international markets including Canada.

Wana Brands has invested in refining its proprietary edibles recipes so that the taste of the company’s delicious ingredients come through—not the taste of medicine—producing artisan level products that are infused--not sprayed--and have undergone rigorous internal and external testing to ensure precise dosage and consistency.

For more information or to schedule an interview, please contact Shawna McGregor at 917-971-7852 or shawna@rosengrouppr.com.

Wana Brands: Enhance Your Life. Wana Brands leads the cannabis infused products industry in quality, consistency and potency. Wana products include a full line of edibles, including our market leading gummies and WanaCapsxr, a family of extended release cannabis capsules that provide symptom relief for up to 12 hours. Wana Brands is the No. 1 ranked edibles brand in sales revenue in the highly competitive Colorado market according to BDS Analytics. Wana products are also available in Oregon and Nevada, and has announced entry into Arizona and Illinois, with more markets readying for launch. For more information, visit www.wanabrands.com.

Media Contact

Shawna McGregor
917 971 7852, shawna@rosengrouppr.com

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

More Info:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.